Oncology Institute
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $99,901 | $98,578 | $94,666 | $85,788 |
Gross Profit | 14,366 | 13,026 | 10,480 | 12,802 |
EBITDA | -12,315 | -14,846 | -16,415 | -13,709 |
EBIT | -13,888 | -16,364 | -17,904 | -13,752 |
Net Income | -16,113 | -15,479 | -16,271 | -15,314 |
Net Change In Cash | 99,901 | 98,578 | 94,666 | 85,788 |
Free Cash Flow | 1,221 | -17,486 | -16,493 | -4,754 |
Cash | 47,402 | 36,424 | 36,055 | 33,488 |
Basic Shares | 75,524 | 74,748 | 74,234 | 73,469 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $324,239 | $252,483 | $203,003 | $187,514 |
Gross Profit | 59,573 | 52,093 | 40,848 | 36,878 |
EBITDA | -70,454 | 8,402 | -7,937 | -11,290 |
EBIT | -76,327 | 3,991 | -11,278 | -14,468 |
Net Income | -83,068 | 1,657 | -10,927 | -14,321 |
Net Change In Cash | 324,239 | 252,483 | 203,003 | 187,514 |
Cost of Revenue | -101,164 | 891 | ||
Free Cash Flow | -40,882 | -67,285 | -35,727 | -685 |
Cash | 33,488 | 14,010 | 114,299 | 5,997 |
Basic Shares | 73,748 | 80,605 | 66,230 | 59,117 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.17 |
2024-06-30 | -$0.17 |
2024-03-31 | -$0.22 |
2023-12-31 | -$0.21 |
